Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Psychedelics Business

News
Psychedelics Briefs: Numinus Wellness, MAPS Public Benefit Corporation
06/29/2022
Tom Valentino, Digital Managing Editor
Numinus Wellness has announced a corporate ketamine-assisted therapy pilot, while MAPS Public Benefit Corp. has selected a contract research organization for the development of a new drug application for MDMA-assisted therapy for PTSD.
Numinus Wellness has announced a corporate ketamine-assisted therapy pilot, while MAPS Public Benefit Corp. has selected a contract research organization for the development of a new drug application for MDMA-assisted therapy for PTSD.
Numinus Wellness has announced a...
06/29/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Dimensions Health Centres, Numinus Wellness
05/19/2022
Tom Valentino, Digital Managing Editor
Dimensions Health Centres has announced plans for a psychedelic retreat campus, and Numinus Wellness has received approval from Health Canada to provide psychedelic-assisted therapy for treatment-resistant depression.
Dimensions Health Centres has announced plans for a psychedelic retreat campus, and Numinus Wellness has received approval from Health Canada to provide psychedelic-assisted therapy for treatment-resistant depression.
Dimensions Health Centres has...
05/19/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Field Trip Health, Nue Life Health, Ketamine Wellness Centers
05/14/2022
Tom Valentino, Digital Managing Editor
Field Trip Health has teamed up with Nue Life Health to offer at-home ketamine therapy treatments, and Ketamine Wellness Centers has partnered with the Veterans Administration in Arizona.
Field Trip Health has teamed up with Nue Life Health to offer at-home ketamine therapy treatments, and Ketamine Wellness Centers has partnered with the Veterans Administration in Arizona.
Field Trip Health has teamed up...
05/14/2022
Behavioral Healthcare Executive
News
Australian Firm Explores Use of VR in Psychedelic-Assisted Psychotherapy
05/12/2022
Tom Valentino, Digital Managing Editor
Enosis Therapeutics Co-Founder Agnieszka Sekula discusses the company’s integration of virtual reality into existing psychedelic-assisted therapy protocols.
Enosis Therapeutics Co-Founder Agnieszka Sekula discusses the company’s integration of virtual reality into existing psychedelic-assisted therapy protocols.
Enosis Therapeutics Co-Founder...
05/12/2022
Psych Congress Network
News
Field Trip Announces Plan to Split Divisions Into Separate Public Companies
05/02/2022
Tom Valentino, Digital Managing Editor
Field Trip Health & Wellness will operate the company’s 12 clinic locations, while Field Trip Discovery, the organization’s research division, will be renamed Reunion Neuroscience.
Field Trip Health & Wellness will operate the company’s 12 clinic locations, while Field Trip Discovery, the organization’s research division, will be renamed Reunion Neuroscience.
Field Trip Health & Wellness...
05/02/2022
Behavioral Healthcare Executive
News
Numinus to Acquire Novamind in Significant Psychedelic Therapy and Research Deal
04/12/2022
Tom Valentino, Digital Managing Editor
Numinus Wellness has entered into an agreement to acquire Novamind in a $26.2 million ($20.77 million US) deal announced by the 2 companies on Tuesday morning.
Numinus Wellness has entered into an agreement to acquire Novamind in a $26.2 million ($20.77 million US) deal announced by the 2 companies on Tuesday morning.
Numinus Wellness has entered...
04/12/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Revitalist, Alchemy Wellness, Diamond Therapeutics, Awakn Life Sciences
03/30/2022
Tom Valentino, Digital Managing Editor
Revitalist Lifestyle and Wellness has acquired Alchemy Wellness in Virginia, while Diamond Therapeutics has completed the last patient visit in its Phase I clinical trial studying low-dose psilocybin, and Awakn Life Sciences’ London clinic...
Revitalist Lifestyle and Wellness has acquired Alchemy Wellness in Virginia, while Diamond Therapeutics has completed the last patient visit in its Phase I clinical trial studying low-dose psilocybin, and Awakn Life Sciences’ London clinic...
Revitalist Lifestyle and...
03/30/2022
Behavioral Healthcare Executive
News
Psychedelic Briefs: Journey Colab, Small Pharma
03/08/2022
Tom Valentino, Digital Managing Editor
Kelly J. Clark, MD, MBA, DFAPA, DFASAM, the former president of the American Society of Addiction Medicine, is joining its Scientific Advisory Board of biopharmaceutical startup Journey Colab, while a clinical trial for DMT-assisted therapy...
Kelly J. Clark, MD, MBA, DFAPA, DFASAM, the former president of the American Society of Addiction Medicine, is joining its Scientific Advisory Board of biopharmaceutical startup Journey Colab, while a clinical trial for DMT-assisted therapy...
Kelly J. Clark, MD, MBA, DFAPA,...
03/08/2022
Behavioral Healthcare Executive
BHE Psychedelics Podcast
BHE Podcast
BHE Psychedelics Podcast, Episode 004 – Paul Thielking, MD, Novamind Chief Scientific Officer
03/04/2022
Paul Thielking, MD, chief scientific officer for Novamind, discusses the company's current clinical trials, how psychedelics are garnering interest from physicians, and issues that will have to be navigated for psychedelics treatments in...
Paul Thielking, MD, chief scientific officer for Novamind, discusses the company's current clinical trials, how psychedelics are garnering interest from physicians, and issues that will have to be navigated for psychedelics treatments in...
Paul Thielking, MD, chief...
03/04/2022
Behavioral Healthcare Executive
BHE Psychedelics Podcast
BHE Podcast
BHE Psychedelics Podcast, Episode 003 – James Lanthier, Mindset Pharma CEO
02/14/2022
Mindset Pharma CEO James Lanthier discusses his organization’s development of next-generation psychedelic drugs and their potential applications for treating various mental health conditions.
Mindset Pharma CEO James Lanthier discusses his organization’s development of next-generation psychedelic drugs and their potential applications for treating various mental health conditions.
Mindset Pharma CEO James...
02/14/2022
Behavioral Healthcare Executive

Advertisement

Stay in the Know

Behavioral Healthcare Executive Newsletter

Popular Articles

Teaching kids with behavioral health problems
06/15/2009
The principal of a school specifically for these children shares his approach
The principal of a school specifically for these children shares his approach
The principal of a school...
06/15/2009
Behavioral Healthcare Executive
News
Under pressure, FDA taking new tack on opioids
02/05/2016
FDA has come under fire several times for new opioid drug approvals, with advocates cautioning that the risk of addiction will only increase. Now, a top agency leader has outlined a plan to better balance the equation. 
FDA has come under fire several times for new opioid drug approvals, with advocates cautioning that the risk of addiction will only increase. Now, a top agency leader has outlined a plan to better balance the equation. 
FDA has come under fire several...
02/05/2016
Behavioral Healthcare Executive
If you build it, they will come
05/01/2009
West End Place is a 50,000-square-foot facility that has three levels. The street level (pictured) is where members and staff work together operating
West End Place is a 50,000-square-foot facility that has three levels. The street level (pictured) is where members and staff work together operating
West End Place is a...
05/01/2009
Behavioral Healthcare Executive
Part 2 workarounds encumber safety net plans
01/12/2016
A new ACAP report finds that 42 CFR Part 2 creates a new stigma--one that stands in the way of coordinated care for those with substance use disorders.
A new ACAP report finds that 42 CFR Part 2 creates a new stigma--one that stands in the way of coordinated care for those with substance use disorders.
A new ACAP report finds that 42...
01/12/2016
Behavioral Healthcare Executive
The Stewart and Lynda Resnick Neuropsychiatric Hospital; Los Angeles
03/30/2009
Click here to view slide
Click here to view slide
Click here to view slide
03/30/2009
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement